|
June 28, 2004
News this month
Hormonal disorder affects many American women
Researchers have found that a complex hormonal disorder affecting women of childbearing age is considerably more common than previously believed. According to a study published in the Journal of Clinical Endocrinology and Metabolism, about 6.6 percent or one in 15 premenopausal women in the United States have polycystic ovary syndrome (PCOS).
One in 15 premenopausal women in the United States have polycystic ovary syndrome (PCOS).
Symptoms
PCOS is characterized by an excess of male hormones that disrupts normal ovulation and leads to symptoms such as irregular or absent menstrual periods and multiple, small ovarian cysts. The high level of androgens, which normally exist at low levels in women, may also result in excess weight, skin problems and an excess of male-type hair growth.
Many women with PCOS are also found to have insulin resistance, a condition that allows high levels of insulin to circulate in the blood, increasing risks of developing Type 2 diabetes, hypertension and heart disease.
This is a syndrome, which means it is a collection of features, said lead researcher Dr. Ricardo Azziz, chair of Cedars-Sinai Medical Center's department of obstetrics and gynecology. Some patients are more severely affected than others. Some are very obese, some are more affected by insulin-resistance. Some are very hairy. Others have no periods at all.
Treatments for the syndrome run the gamut, from birth control pills and androgen-lowering drugs to insulin-sensitizing medications and anti-hair growth drugs. Some experts also suggest a diet low in processed carbohydrates and exercise.
New study indicates higher percentage
In an earlier study of 277 18- to 45-year-old women, Dr. Azziz and his colleagues found that PCOS affected an estimated 4 percent of reproductive-age women, a lower percentage than has been found in studies in Greece, the United Kingdom and Spain. The largest patient sample in those studies was 230.
PCOS is the most common endocrine abnormality of reproductive-aged
women.
Dr. Azziz
According to the new study of 400 women, about 6.6 percent of premenopausal women in the United States have PCOS, an estimate that is comparable to those found in the European studies. The analysis was based on the results of medical histories, physical exams and lab results of women, age 18 to 45, who were undergoing pre-employment physicals at the University of Alabama, Birmingham.
This is the single largest study concerning the prevalence of the Polycystic Ovary Syndrome in this country, and the data support the concept that PCOS is the most common endocrine abnormality of reproductive-aged women, said Dr. Azziz.
The manner in which patients are recruited for a study can significantly impact the results. For example, several PCOS studies have recruited patients for a health evaluation or a study of women's health issues. It is possible that these offers could inadvertently skew the sample by attracting a higher-than-average number of respondents who have medical conditions. The researchers attempted to avoid this potential bias by having an unselected group of women, not those seeking treatment or a clinical trial.
Treatment often focuses on symptoms rather than cause
Because the disorder often goes undiagnosed, many women struggle with symptoms and complications such as acne, infertility, obesity and/or hirsutism without addressing the underlying cause. In this study, for example, about 75 percent of the women with PCOS had unusual hair growth, 24 percent were overweight and 32 percent were obese.



Physician Referral
Online
A free and confidential service
of Yale-New Haven Hospital.
Physician Referral Online
Using your own criteria, you can request information from a database
of 900 area physicians who have registered to participate.
Request an appointment
We would be happy to assist you in scheduling an appointment with
a member of the hospital's medical staff. Use the link above or
call:
203-688-2000
or toll-free
1-888-700-6543
to talk with a referral coordinator.
 
For the 12th year in a row, Yale-New Haven
has been highly ranked by U.S. News & World Report for
its programs in gynecology. |

|

Education, assessment and treatment essential for PCOS
Our awareness of the prevalence of polycystic ovary syndrome has increased considerably over the last decade or so. This condition was first recognized as a distinct disorder in 1935 and was called Stein-Leventhal syndrome after the physicians who identified it. Its current name is derived from the characteristic changes that may occur in the ovaries, which become enlarged and covered with small fluid-filled cysts.
PCOS is both a hormonal disorder and a metabolic one, associated with insulin resistance.
Today, we have a better understanding of PCOS and its relationship to the metabolic syndrome that we talk about in relation to heart disease. We recognize it as both a hormonal disordermarked by the excess production of androgensand a metabolic one, associated with insulin resistance, a condition where increased production of insulin is required in order to maintain a normal level of blood sugar.
Connection to obesity
One reason we may be hearing more about PCOS is its connection to obesity. As women get heavier, PCOS becomes more severe. We are not sure at this point whether PCOS predisposes women to gain weight or if weight gain results in a higher incidence of PCOS, but we do know there's a definite relationship. Two-thirds of PCOS patients are overweight. Most are insulin resistant.
Symptoms and risks
Adolescent girls often present with irregular menstrual periods or no periods at all; dark, thickened skin around the neck, armpits or below breasts; acne and excess body hair. Young adults may seek medical attention for fertility issues, another symptom of the syndrome.
The skin patches are a marker of high insulin levels, and it is this aspect of the condition that may have the most serious long-term effectsan increased risk of cardiovascular disease and heart attacks. Long-term menstrual irregularities are also suspected to result in precancerous changes in the lining of the uterus and the development of endometrial cancer.
Genetic predisposition
We do know PCOS tends to run in families, but the exact role of genetics is not understood. Diagnosing the syndrome is a process of ruling out other conditions. There is not a definitive blood test or imaging exam that confirms the presence of PCOS. We rule out other conditions such as an underactive thyroid or adrenal or pituitary abnormalities that could account for the symptoms. Ovarian cysts are often present, but they are not enough to confirm a diagnosis since many women who have cysts do not have PCOS.
Treatment options
We often prescribe lifestyle modifications such as diet and exercise for overweight women. Significant weight loss can result in an improvement or even a remission of symptoms. Women who are insulin resistant are treated with medications such as glucophage (metformin), which helps with weight control, blood sugar management and fertility. For women whose periods continue to be irregular, we prescribe fertility drugs or birth control drugs. Women bothered by heavy body hair can be treated with medications that block the production or action of androgen.
Treating PCOS patients for insulin resistance and obesity are important to their long-term health since they are at risk for several serious health conditions.
Evaluation essential to curtail bad outcomes
PCOS is the most common hormonal problem of premenopausal women. Education about the symptoms and the availability of treatment options are important to get women in to see their physicians for a complete endocrine evaluation. Treating PCOS patients for insulin resistance and obesity are important to their long-term health since they are at risk for several serious health conditions.
PCOS patients are two to three times more likely to miscarry during their reproductive years and develop uterine cancer later in life. They are at risk for developing diabetes, hypertension and cardiovascular disease. Research has shown that these women in their late 20s and early 30s already show evidence of thickened arterial walls and unhealthy lipid profiles.
There is no single specialist who treats PCOS, and symptoms may be treated individually, based on what's most troubling to the woman and what kind of physician she consults. Gynecologists may be more inclined to treat the menstrual and fertility issues, while a dermatologist would focus on the acne and an endocrinologist on insulin issues.
It's important to see that these symptoms may be connected to an underlying condition and to seek someone who has some expertise in PCOS.
Because of the risk of developing serious medical conditions, it is important for any woman who is experiencing the symptoms we've talked aboutirregular or absent periods, unusual body hair growth, unusually severe acne, darkened skin patches and rapid weight gainto be evaluated and treated as soon as possible.
Dr. Duleba is a board-certified specialist in obstetrics and gynecology as well as reproductive endocrinology and infertility. He is an associate professor at the Division of Reproductive Endocrinology and Infertility at the Yale University School of Medicine.
|